Continuing The Conversation: How the Popularity of Ozempic Has Fueled Shortages, Misconception About Its Usage

On last week’s Monday episode, obesity specialist Veronica Johnson, MD, joined the show to give an overview about how GLP-1 drugs like Ozempic work and how they’re being incorporated into patient care. On this week’s episode, we hear the second part of that conversation and delve into the shortages of the medication as well as other access barriers faced by some patients.

You can listen to part one of that conversation here.

Hosted on Acast. See acast.com/privacy for more information.